NQO1 and asthma: Based on our findings, LOL effectively attenuated airway inflammation and oxidative stress by suppressing of MAPKs and p65NF-κB activation, and by activating of Nrf-2/HO-1/NQO1 signaling in the OVA-challenged asthma model.